NZ631118A - Methods for treating nasal polyposis by administering an il-4r antagonist - Google Patents
Methods for treating nasal polyposis by administering an il-4r antagonistInfo
- Publication number
- NZ631118A NZ631118A NZ631118A NZ63111814A NZ631118A NZ 631118 A NZ631118 A NZ 631118A NZ 631118 A NZ631118 A NZ 631118A NZ 63111814 A NZ63111814 A NZ 63111814A NZ 631118 A NZ631118 A NZ 631118A
- Authority
- NZ
- New Zealand
- Prior art keywords
- administering
- nasal polyposis
- antagonist
- methods
- treating nasal
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ752224A NZ752224B2 (en) | 2013-06-21 | 2014-06-20 | Methods for treating nasal polyposis by administering an il-4r antagonist |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361837912P | 2013-06-21 | 2013-06-21 | |
EP14305670 | 2014-05-07 | ||
PCT/US2014/043440 WO2014205365A1 (en) | 2013-06-21 | 2014-06-20 | Methods for treating nasal polyposis by administering an il-4r antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ631118A true NZ631118A (en) | 2019-05-31 |
Family
ID=66440559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ631118A NZ631118A (en) | 2013-06-21 | 2014-06-20 | Methods for treating nasal polyposis by administering an il-4r antagonist |
Country Status (10)
Country | Link |
---|---|
JP (3) | JP6640977B2 (hu) |
DK (1) | DK3010539T3 (hu) |
ES (1) | ES2747630T3 (hu) |
HR (1) | HRP20191709T1 (hu) |
HU (1) | HUE046410T2 (hu) |
LT (1) | LT3010539T (hu) |
NZ (1) | NZ631118A (hu) |
PT (1) | PT3010539T (hu) |
SG (1) | SG10201912898XA (hu) |
TW (1) | TWI707694B (hu) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7608693B2 (en) * | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
EP2414520A2 (en) * | 2009-03-31 | 2012-02-08 | Altair Therapeutics, Inc. | Methods of modulating an immune response to a viral infection |
UA111731C2 (uk) * | 2010-10-06 | 2016-06-10 | Рідженерон Фармасьютікалз, Інк. | Стабілізована композиція, яка містить антитіло до рецептора інтерлейкіну-4 (іl-4r), варіанти |
RS59354B1 (sr) * | 2013-06-21 | 2019-10-31 | Sanofi Biotechnology | Postupci lečenja nosne polipoze davanjem il-4r antagonista |
-
2014
- 2014-06-20 HU HUE14742021A patent/HUE046410T2/hu unknown
- 2014-06-20 SG SG10201912898XA patent/SG10201912898XA/en unknown
- 2014-06-20 PT PT147420210T patent/PT3010539T/pt unknown
- 2014-06-20 TW TW108101935A patent/TWI707694B/zh active
- 2014-06-20 LT LTEP14742021.0T patent/LT3010539T/lt unknown
- 2014-06-20 NZ NZ631118A patent/NZ631118A/en unknown
- 2014-06-20 DK DK14742021.0T patent/DK3010539T3/da active
- 2014-06-20 ES ES14742021T patent/ES2747630T3/es active Active
-
2018
- 2018-12-27 JP JP2018243929A patent/JP6640977B2/ja active Active
-
2019
- 2019-09-19 HR HRP20191709 patent/HRP20191709T1/hr unknown
- 2019-12-25 JP JP2019233649A patent/JP6898421B2/ja active Active
-
2021
- 2021-06-09 JP JP2021096260A patent/JP2021138743A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
HRP20191709T1 (hr) | 2019-12-13 |
TW201940193A (zh) | 2019-10-16 |
TWI707694B (zh) | 2020-10-21 |
SG10201912898XA (en) | 2020-02-27 |
JP2019069987A (ja) | 2019-05-09 |
ES2747630T3 (es) | 2020-03-11 |
HUE046410T2 (hu) | 2020-03-30 |
JP2020073525A (ja) | 2020-05-14 |
PT3010539T (pt) | 2019-10-14 |
JP6898421B2 (ja) | 2021-07-07 |
LT3010539T (lt) | 2019-10-10 |
JP6640977B2 (ja) | 2020-02-05 |
DK3010539T3 (da) | 2019-10-21 |
NZ752224A (en) | 2020-11-27 |
JP2021138743A (ja) | 2021-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2014284235B2 (en) | Methods for treating nasal polyposis by administering an IL-4R antagonist | |
NZ706377A (en) | Il-6 antagonists and uses thereof | |
MX2023000079A (es) | Composiciones farmaceuticas que comprenden un antagonista de il-4r para usarse en el tratamiento de sinusitis cronica con polipos nasales. | |
MX353931B (es) | Anticuerpos que se unen a ox40 y sus usos. | |
PH12015502293A1 (en) | Bispecific antibodies specific for fap and dr5, antibodies specific for dr5 and methods of use | |
PH12015500390B1 (en) | Antibodies and vaccines for use in treating ror1 cancers and inhibiting metastasis | |
MX2021008113A (es) | Composiciones farmaceuticas que comprenden un antagonista de il-4r para usarse en el tratamiento del asma. | |
TN2015000247A1 (en) | Bcma antigen binding proteins | |
MX2015002292A (es) | Metodos para tratar o prevenir asma administrando un antagonista de il-4r. | |
CA2813849C (en) | Secukinumab for use in the treatment of ankylosing spondylitis | |
MX341076B (es) | Formulaciones estables de anticuerpos para el receptor humano pd-1 de meurte programada y tratamientos relacionados. | |
TN2014000120A1 (en) | Cd27l antigen binding proteins | |
PH12014501783B1 (en) | Anti-lipoarabinomannan antibody and immunoassay for acid-fast bacillary infection using the antibody | |
MX2014005728A (es) | Anticuerpos especificos para antigeno de la superficie celular de trofoblasto-2 y sus usos. | |
PH12015501505B1 (en) | Antibodies that bind to tl1a and their uses | |
CY1122132T1 (el) | Μεθοδοι για τη μειωση των ρυθμων εξαρσης του ασθματος με χρηση μπενραλιζουμαμπης | |
MX2013011706A (es) | Proteinas novedosas de enlace a antigeno. | |
NZ629553A (en) | Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof | |
NZ630864A (en) | Use of semaphorin-4d binding molecules to promote neurogenesis following stroke | |
MX2015005928A (es) | Metodos para tratar el cancer de ovario con antagonistas de dll4. | |
MY184189A (en) | Methods of treating nail and scalp psoriasis | |
PH12015500752A1 (en) | Her3 antigen binding proteins binding to the beta-hairpin of her3 | |
PH12015500751A1 (en) | Anti-her3/her4 antigen binding proteins binding to the beta-hairpin of her3 and beta-hairpin of her4 | |
NZ631118A (en) | Methods for treating nasal polyposis by administering an il-4r antagonist | |
MX2016014726A (es) | Proteinas de union al antigeno her1 que se unen a la beta-horquilla de her1. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ASS | Change of ownership |
Owner name: REGENERON PHARMACEUTICALS, INC., US Effective date: 20161201 Owner name: SANOFI BIOTECHNOLOGY, FR Effective date: 20161201 |
|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 20 JUN 2021 BY WATERMARK INTELLECTUAL PROPERTY PTY LTD. Effective date: 20190911 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 JUN 2022 BY CPA GLOBAL Effective date: 20210506 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 JUN 2023 BY CPA GLOBAL Effective date: 20220505 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 JUN 2024 BY CPA GLOBAL Effective date: 20230504 |